The new facility will be home to Precision NanoSystems’s new global headquarters and include multiple GMP suites for manufacturing RNA therapeutics and vaccines.
Moderna has signed a Memorandum of Understanding with the government of Canada to build a mRNA vaccine manufacturing facility in the country: which could serve as a model for similar partnerships around the world.
June 25, 2021
published at 2:40 AMACN Newswire
Seoul, Korea, June 25, 2021 - (ACN Newswire) - Avantor, a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies and applied materials industries, was named best company in bioprocessing excellence for single-use solutions and best bioprocessing supplier for upstream processing at Biologics Manufacturing Korea (BMK) 2021.
Sang Kyu Lee, Representative Director - Avantor Korea/Japan(centre), Jin Young Lee, Biopharma Business Manager - Avantor Korea/Japan(left), James Hwang, Innovation Center Field Application & Education Manager - Avantor Korea/Japan(right), after receiving the Awards for Best Company in Single-use Solutions and Upstream Processing at BMK 2021.